|
Classes to be Reviewed
(to be posted in April 2012)
Registration for Public Testimony
Public testimony at the May 10, 2012 Pharmacy and Therapeutics Committee meeting will be limited to fifteen (15) presentations: twelve (12) speakers from the drug industry and three (3) representing consumer interests. To the extent that the full allotment for either group does not pre-register to speak, representatives from the other group will be selected in their place. In the event speakers are selected and fail to appear at the meeting, their time will be forfeited, and that slot will remain unfilled. We will start calling on speakers at approximately 9:20 a.m. This part of the meeting will last approximately one hour and fifteen minutes. Speakers will be called upon to give their presentations
in the order that their names are drawn in the speaker lottery. The time available for each presentation is up to five minutes. Thirty seconds before the end of the presentation, speakers will receive a warning that time has almost expired.
To register, potential speakers must complete the form at
MarylandPDLQuestions. The
deadline for registering to speak at the May 10, 2012 meeting is April 26, 2012. Only one speaker per company, or organization may register to speak. In the case of subsidiaries of conglomerates, one speaker from each subsidiary may register to speak. Speakers may share their time slots. However, there may be only one time slot given to a company or subsidiary.
In the event more speakers have registered than there are spaces available, a lottery will be held to select 15 companies and consumers at random on the day after the deadline. A disinterested party in the presence of witnesses will draw the names. All registrants will be notified within twenty-four hours of the drawing, whether or not they have been selected. Winners will be advised of their position in the order of speakers.
After being selected, if you have a change in your choice of person to speak, please notify P&T Committee staff as soon as possible.
Speakers are asked to provide two business cards to the registration attendant at the meeting.
Speakers' handout information must be submitted to the Maryland Pharmacy Program (MPP) electronically at least two days prior to the meeting. Pharmacy Program staff will distribute the handouts to the P&T Committee members and staff prior to speakers taking the microphone. Handouts are limited to no more than two standard 8-1/2 by 11 inch pages of “bulleted” points (or one page front and back) per five-minute time-slot. At the meeting, speakers are required to state their name, organization and city of business. Audio-visual equipment will not be allowed because of the time constraint.
Submission
of Written Material to Committee
Written information from consumers or drug manufacturing companies who are not one of the selected speakers may be submitted to the Pharmacy and Therapeutics Committee. E-mail communication is preferred; however, it must be compatible with MS-Word or in Adobe® Acrobat® format. The Pharmacy Program will forward e-mails received before May 3 to the members of the Committee. Charts and graphs may be submitted in MS-Excel® or Adobe® Acrobat®. Attach your material to an e-mail to:
MarylandPDLQuestions@dhmh.state.md.us. Hard copies of written information may be mailed or delivered to Clinical Pharmacy Services Division, Room 408, Dept. of Health and Mental Hygiene, 201 W. Preston St., Baltimore, MD 21201. If the information is contained on two pages or less, we will copy it and send it to the P&T Committee members. If it is more than 2 pages, please enclose at least 13 copies packaged in individual envelopes with sufficient US postage attached. The Pharmacy Program will affix address labels to your envelopes and forward them to the P&T Committee members. Materials received with insufficient postage will not be forwarded. Binders and heavy material must be placed in individual padded envelopes. To ensure sufficient time for review, the mailed material must be received at DHMH at least two weeks prior to the meeting.
|